Happy New Year! If you own stock, 2017 was a good year: the Dow closed Friday at 24,719—up 25% for the year, its 4th strongest on record since 1997. Ditto…
Read More
2018 is shaping up to be a pivotal year in U.S. healthcare with implications for decades to come. Here’s the eight areas where boards and management teams will see major…
Coverage about the Aetna acquisition by CVS has been pervasive since last Monday’s announcement. The headlines in national, local and trade industry outlets reflect the balance of intrigue and skepticism…
Last week, after a workout, a physician pulled me aside and asked “is there another profession like medicine where the provider of the service has no control about what they’re…
Entering the home stretch on 2017, the stage is set for some classic duals next year: they’re about money and control and they’re playing out already across the industry. Here’s…
Friday at the annual meeting of the Council of Medical Specialty Societies meeting in Washington, I was asked if alternative payment models are likely to be around in coming years….
Last week, I had the honor of delivering the Russ Coile Memorial Lecture at George Washington University in DC. I was asked to offer a long-term perspective about the future…
In DC, the current focus of Congress’ attention is the GOP’s Tax Cuts and Jobs Act tax reform package introduced Thursday. As proposed, it lowers corporate tax rates, eliminates or…
New York Times’ healthcare journalist Reed Abelson contacted me Thursday about the proposed acquisition of Aetna by CVS. She asked if I was surprised: I replied no. Big deals in…
The Board’s Fourth Imperative: Monitoring Culture The reputations of Wells Fargo, Uber, Equifax, Weinstein, Fox News, the University of Louisville basketball program and many others are tarnished as a result…
